The effects of methylphenidate on weight, height, and body mass index in Turkish children and adolescents with ADHD

被引:3
|
作者
Turan, Serkan [1 ]
PEKCANLAR Akay, Aynur [2 ]
机构
[1] Odemis State Hosp, Dept Child & Adolescent Psychiat, TR-35750 Izmir, Turkey
[2] Dokuz Eylul Univ, Dept Child & Adolescent Psychiat, Med Fac, Izmir, Turkey
关键词
methylphenidate; attention-deficit hyperactivity disorder; height; weight; BMI; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GROWTH; ASSOCIATION;
D O I
10.5455/apd.51135
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The pathophysiological mechanisms underlying the effects of psychostimulants (methylphenidate) treatment on growth still remain controversial. We examined the long term effects of methylphenidate on height, weight and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder (ADHD). Methods: Participants (6-18 years, 330 boys, 103 girls) diagnosed with ADHD who received treatment with methylphenidate for at least 1 year at the Department of Child and Adolescent Psychiatry at Dokuz Eylul University Medical School were included in a retrospective study. Weight, height, and BMI z scores were converted to age- and gender-corrected z scores using norms from the Turkish population at baseline and last follow-up. Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS (SDS]: 0.74 +/- 1.43, followup height-SDS [SDS]: -0.67 +/- 4.35, t-test p<0.001; baseline weight SDS [SDS]: 0.61 +/- 1.28, and follow-up weight-SDS [SDS]: -0.41 +/- 0.76, t-test p<0.001). There were no differences in BMI-SDS before and after stimulant treatment (baseline BMI-SDS [SDS]: 0.27 +/- 1.21, follow-up BMI-SDS [SDS]: -0.20 +/- 4.54, t-test p=0.353). However, considering whether patients were children (6-12 years) or adolescents (13-18 years) when they started medication, in the group of children, height and BMI was affected by treatment (baseline height-SDS [SDS]: 0.87 +/- 1.42; follow-up height-SDS [SDS]: -0.78 +/- 4.81]; p=0.002; baseline BMI-SDS [SDS]: 0.29 +/- 1.19; follow-up BMI-SDS [SDS]: -0.21 +/- 0.69; p<0.001). Results of multiple linear regression analysis which assess the possible contribution of the different treatment-related factors, only age starting treatment (B=-0.039, p=0.011) predicted final weight. Conclusions: We conclude that methylphenidate shows a negative effect on height and BMI in children. It was thought that the findings obtained at the end of the study might be helpful in assessing the growth parameters that may facilitate the course of the ADHD, and in the improvement of more efficient and permanent treatment approaches, and the adherence of patients to the treatment.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [41] Understanding Accelerated Summer Body Mass Index Gain by Tracking Changes in Children's Height, Weight, and Body Mass Index Throughout the Year
    Weaver, R. Glenn
    White III, James W.
    Finnegan, Olivia
    Armstrong, Bridget
    Beets, Michael W.
    Adams, Elizabeth L.
    Burkart, Sarah
    Dugger, Roddrick
    Parker, Hannah
    von Klinggraeff, Lauren
    Bastyr, Meghan
    Zhu, Xuanxuan
    Bandeira, Alexsandra S.
    Reesor-Oyer, Layton
    Pfledderer, Christopher D.
    Moreno, Jennette P.
    CHILDHOOD OBESITY, 2024, 20 (03) : 155 - 168
  • [42] Height, weight, and body mass index in patients with familial dysautonomia
    Cotrina, Maria L.
    Morgenstein, Barr
    Perez, Miguel
    Norcliffe-Kaufmann, Lucy
    Palma, Jose-Alberto
    Kaufmann, Horacio
    PLOS ONE, 2023, 18 (11):
  • [43] Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD
    Pelham, William E., Jr.
    Gnagy, Elizabeth M.
    Sibley, Margaret H.
    Kipp, Heidi L.
    Smith, Bradley H.
    Evans, Steven W.
    Bukstein, Oscar
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (02) : 129 - 136
  • [44] A retrospective analysis of the short-term effects of olanzapine and quetiapine in children on weight and body mass index and adolescents
    Patel, NC
    Kistler, JS
    James, EB
    Crismon, ML
    PHARMACOTHERAPY, 2004, 24 (07): : 824 - 830
  • [45] Anthropometric Parameters in Asthmatic Children and the Relationship of Childhood Asthma with Height, Weight and Body Mass Index
    Bazargan, Nasrin
    Hamidifar, Shokouh
    Khalouei, Ali
    Sedighi, Gholamreza
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2019, 27 (05)
  • [46] Secular trend in body height and weight of Australian children and adolescents
    Loesch, DZ
    Stokes, K
    Huggins, RM
    AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, 2000, 111 (04) : 545 - 556
  • [47] Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands
    Fredriks, AM
    van Buuren, S
    Jeurissen, SER
    Dekker, FW
    Verloove-Vanhorick, SP
    Wit, JM
    ACTA PAEDIATRICA, 2004, 93 (06) : 817 - 824
  • [48] Ethnic Differences in Body Mass Index, Weight and Height Among School Children in the North of Iran
    Veghari, Gholamreza
    EURASIAN JOURNAL OF MEDICINE, 2012, 44 (01): : 22 - 27
  • [49] Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
    Iijima, Mayuko
    Stall, Melanie
    Wang, Lei
    Panetta, John C.
    Triplett, Brandon M.
    Pui, Ching-Hon
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Pounds, Stanley B.
    Inaba, Hiroto
    BLOOD ADVANCES, 2022, 6 (09) : 2824 - 2834
  • [50] Body Mass Index and Cardiovascular Risk Factors in Children and Adolescents with High Birth Weight
    Ledo, Daniel L.
    Suano-Souza, Fabiola Isabel
    Franco, Maria do Carmo P.
    Strufaldi, Maria Wany L.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 (04) : 272 - 278